Nasus Pharma to Participate in Upcoming Investor Conferences

About this update from Nasus Pharma Ltd.

[{"type":"image","alt":"Nasus Pharma, Ltd.","displaySize":"","headline":null,"caption":"Nasus Pharma, Ltd.","className":"","disableSlideshowImg":false,"size":{"original":{"width":241,"height":136,"url":"https://media.zenfs.com/en/globenewswire.com/f80d312befe1c63984fc7bf025e58d6d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/quoV9o_G7y0qGuyE83dEZQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIzNztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f80d312befe1c63984fc7bf025e58d6d","width":241,"height":136}},"lazy":false},{"type":"text","content":"TEL AVIV, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that Company management will participate in upcoming investor conferences in February and March.","length":344,"tagName":"p"},{"type":"text","content":"Oppenheimer 36th Annual Healthcare Life Sciences Conference","length":59,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Date and time: February 25, 2026, 1:20 p.m. ET","length":46,"tagName":"p"}]},{"val":[{"type":"text","content":"Location: Virtual (register here: https://event.summitcast.com/view/CTtthLh2Bi2D9aYoKpvtEv/KoYPJS8x3zqMuXPHfEHoSY)","length":114,"tagName":"p"}]},{"val":[{"type":"text","content":"Format: Company presentation","length":28,"tagName":"p"}]},{"val":[{"type":"text","content":"Speaker: Dan Teleman, Chief Executive Officer","length":45,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":233,"olType":false},{"type":"text","content":"BIO Investment & Growth Summit ","length":34,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Date and time: March 2, 2026, 10:15 a.m. ET","length":43,"tagName":"p"}]},{"val":[{"type":"text","content":"Location: Miami, FL","length":19,"tagName":"p"}]},{"val":[{"type":"text","content":"Format: Company presentation","length":28,"tagName":"p"}]},{"val":[{"type":"text","content":"Speaker: Dan Teleman, Chief Executive Officer","length":45,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":135,"olType":false},{"type":"text","content":"Citizens Life Sciences Conference","length":33,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Date and time: March 11, 2026, 3:25 p.m. ET","lengt...

More updates from Nasus Pharma Ltd.